Document is current
Any future updates will be listed below
-
Authors
Kawabata, Ryohei https://orcid.org/0000-0001-7386-1096
Nishikawa, Kazuhiro
Kawase, Tomono
Kawada, Junji
Kimura, Yutaka
Kashima, Yasushige
Ueda, Shugo
Takeno, Atsushi
Shimomura, Kazuhiro
Imamura, Hiroshi
-
Funding
Funding for this research was provided by:
Abbott Japan
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 5 March 2025
First Online: 19 March 2025
Declarations
:
: The authors declare the following financial interests/personal relationships, which may be considered potential competing interests: KN has received honoraria from Bristol-Myers Squibb Co. Ltd, Daiichi Sankyo, EA Pharm Co. Ltd, Eli Lilly Japan KK, MSD KK, Ono Pharmaceutical Co. Ltd, Otsuka Pharmaceutical Co. Ltd., Taiho Pharmaceutical Co. Ltd, and Yakult Honsha Co. Ltd. KS has received honoraria from Ono Pharmaceutical Co. Ltd. All remaining authors have declared no conflicts of interest.
: All procedures were performed in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national), Japanese Clinical Trials Act, and with the Helsinki Declaration of 1964 and later versions. Informed consent should for the study, or an equivalent, was obtained from all patients.
: This article does not contain any studies using animal subjects performed by any of the authors.
Free to read: This content has been made available to all.
